v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect of Adoption of ASU 2025-07
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect of Adoption of ASU 2025-07
Beginning Balance at Dec. 31, 2024 $ 733,545 $ 5,404 $ 836 $ 2,298,661 $ 679 $ (1,566,631) $ 5,404
Beginning Balance, Shares at Dec. 31, 2024     83,633,069        
Purchase of common stock under ESPP 1,501   $ 1 1,500      
Purchase of common stock under ESPP, Shares     90,436        
Issuance of common stock and pre-funded warrants, net of issuance costs 470,478   $ 162 470,316      
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares     16,151,686        
Vesting of restricted common stock     $ 6 (6)      
Vesting of restricted common stock, Shares     607,196        
Stock-based compensation 26,682     26,682      
Exercise of common stock options 719   $ 1 718      
Exercise of common stock options, Shares     74,707        
Other comprehensive income (loss) (519)       (519)    
Net loss (108,330)         (108,330)  
Ending Balance at Mar. 31, 2025 1,129,480   $ 1,006 2,797,871 160 (1,669,557)  
Ending Balance, Shares at Mar. 31, 2025     100,557,094        
Beginning Balance at Dec. 31, 2024 733,545 $ 5,404 $ 836 2,298,661 679 (1,566,631) $ 5,404
Beginning Balance, Shares at Dec. 31, 2024     83,633,069        
Net loss (323,039)            
Ending Balance at Sep. 30, 2025 972,656   $ 1,014 2,855,118 790 (1,884,266)  
Ending Balance, Shares at Sep. 30, 2025     101,359,765        
Beginning Balance at Mar. 31, 2025 1,129,480   $ 1,006 2,797,871 160 (1,669,557)  
Beginning Balance, Shares at Mar. 31, 2025     100,557,094        
Issuance of common stock and pre-funded warrants, net of issuance costs (4)     (4)      
Vesting of restricted common stock     $ 1 (1)      
Vesting of restricted common stock, Shares     81,163        
Stock-based compensation 24,367     24,367      
Exercise of common stock options 1,755   $ 1 1,754      
Exercise of common stock options, Shares     120,491        
Other comprehensive income (loss) (150)       (150)    
Net loss (102,138)         (102,138)  
Ending Balance at Jun. 30, 2025 1,053,310   $ 1,008 2,823,987 10 (1,771,695)  
Ending Balance, Shares at Jun. 30, 2025     100,758,748        
Purchase of common stock under ESPP 1,263   $ 1 1,262      
Purchase of common stock under ESPP, Shares     84,272        
Vesting of restricted common stock     $ 1 (1)      
Vesting of restricted common stock, Shares     95,580        
Stock-based compensation 22,747     22,747      
Issuance of common stock for acquisition 6,715   $ 4 6,711      
Issuance of common stock for acquisition, Shares     403,128        
Exercise of common stock options 412     412      
Exercise of common stock options, Shares     18,037        
Other comprehensive income (loss) 780       780    
Net loss (112,571)         (112,571)  
Ending Balance at Sep. 30, 2025 972,656   $ 1,014 2,855,118 790 (1,884,266)  
Ending Balance, Shares at Sep. 30, 2025     101,359,765        
Beginning Balance at Dec. 31, 2025 1,238,358   $ 1,017 2,877,449 1,111 (1,641,219)  
Beginning Balance, Shares at Dec. 31, 2025     101,748,962        
Purchase of common stock under ESPP 1,510   $ 1 1,509      
Purchase of common stock under ESPP, Shares     74,518        
Vesting of restricted common stock     $ 7 (7)      
Vesting of restricted common stock, Shares     720,697        
Stock-based compensation 19,044     19,044      
Exercise of common stock options 2,025   $ 2 2,023      
Exercise of common stock options, Shares     197,671        
Other comprehensive income (loss) (2,181)       (2,181)    
Net loss (94,318)         (94,318)  
Ending Balance at Mar. 31, 2026 1,164,438   $ 1,027 2,900,018 (1,070) (1,735,537)  
Ending Balance, Shares at Mar. 31, 2026     102,741,848        
Beginning Balance at Dec. 31, 2025 $ 1,238,358   $ 1,017 2,877,449 1,111 (1,641,219)  
Beginning Balance, Shares at Dec. 31, 2025     101,748,962        
Exercise of common stock options, Shares 686,283            
Net loss $ (351,401)            
Ending Balance at Sep. 30, 2026 952,674   $ 1,034 2,947,694 3,434 (1,992,620)  
Ending Balance, Shares at Sep. 30, 2026     103,443,235        
Beginning Balance at Mar. 31, 2026 1,164,438   $ 1,027 2,900,018 (1,070) (1,735,537)  
Beginning Balance, Shares at Mar. 31, 2026     102,741,848        
Vesting of restricted common stock     $ 1 (1)      
Vesting of restricted common stock, Shares     74,578        
Stock-based compensation 19,278     19,278      
Exercise of common stock options 7,523   $ 5 7,518      
Exercise of common stock options, Shares     448,210        
Other comprehensive income (loss) (1,119)       (1,119)    
Net loss (122,678)         (122,678)  
Ending Balance at Jun. 30, 2026 1,067,442   $ 1,033 2,926,813 (2,189) (1,858,215)  
Ending Balance, Shares at Jun. 30, 2026     103,264,636        
Purchase of common stock under ESPP 1,368   $ 1 1,367      
Purchase of common stock under ESPP, Shares     66,473        
Vesting of restricted common stock, Shares     71,724        
Stock-based compensation 18,555     18,555      
Exercise of common stock options 959     959      
Exercise of common stock options, Shares     40,402        
Other comprehensive income (loss) (1,245)       (1,245)    
Net loss (134,405)         (134,405)  
Ending Balance at Sep. 30, 2026 $ 952,674   $ 1,034 $ 2,947,694 $ 3,434 $ (1,992,620)  
Ending Balance, Shares at Sep. 30, 2026     103,443,235